Mohammad Saffarioun, CEO of Aryogen Pharmed announced that recombinant coagulation factor VIII has obtained marketing authorization. read more
A high-ranking delegation from the Indonesian Innovation and Technology Agency (BRIN) visited AryoGen Pharmed read more
